{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Magnetic+Resonance+Image+%28MRI%29", "query": { "intervention": "Magnetic Resonance Image (MRI)" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 288, "total_pages": 29, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Magnetic+Resonance+Image+%28MRI%29&page=2&page_size=10", "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-09-26T02:55:01.380Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT02356159", "title": "Study of Palifermin (Kepivance) in Persons Undergoing Unrelated Donor Allogeneic Hematopoietic Cell Transplantation", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Myelodysplastic Syndromes", "Hodgkin's Lymphoma", "Non-Hodgkin's Lymphoma", "Acute Leukemia", "Multiple Myeloma" ], "interventions": [ { "name": "Rituximab", "type": "BIOLOGICAL" }, { "name": "Conditioning chemotherapy", "type": "DRUG" }, { "name": "TMS", "type": "DRUG" }, { "name": "FLAG", "type": "DRUG" }, { "name": "EPOCH-F", "type": "DRUG" }, { "name": "Hematopoietic stem cell transplant", "type": "PROCEDURE" }, { "name": "Palifermin", "type": "DRUG" }, { "name": "Acetaminophen", "type": "DRUG" }, { "name": "Diphenhydramine", "type": "DRUG" }, { "name": "Prednisone", "type": "DRUG" }, { "name": "Epinephrine", "type": "DRUG" }, { "name": "IV Saline", "type": "OTHER" }, { "name": "ECG", "type": "DIAGNOSTIC_TEST" }, { "name": "ECHO", "type": "DIAGNOSTIC_TEST" }, { "name": "MUGA", "type": "DIAGNOSTIC_TEST" }, { "name": "DEXA", "type": "DIAGNOSTIC_TEST" }, { "name": "CT chest", "type": "DIAGNOSTIC_TEST" }, { "name": "PET", "type": "DIAGNOSTIC_TEST" }, { "name": "MRI", "type": "DIAGNOSTIC_TEST" }, { "name": "BM aspirate", "type": "PROCEDURE" }, { "name": "BM biopsy", "type": "PROCEDURE" }, { "name": "Lumbar puncture", "type": "PROCEDURE" } ], "intervention_types": [ "BIOLOGICAL", "DRUG", "PROCEDURE", "OTHER", "DIAGNOSTIC_TEST" ], "sponsor": "National Cancer Institute (NCI)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 34, "start_date": "2015-09-24", "completion_date": "2025-03-25", "has_results": true, "last_update_posted_date": "2025-09-30", "last_synced_at": "2026-09-26T02:55:01.380Z", "location_count": 2, "location_summary": "Bethesda, Maryland • Minneapolis, Minnesota", "locations": [ { "city": "Bethesda", "state": "Maryland" }, { "city": "Minneapolis", "state": "Minnesota" } ], "official_url": "https://clinicaltrials.gov/study/NCT02356159" }, { "nct_id": "NCT06090903", "title": "Magnetic Resonance Imaging for Improving Knowledge of Brain Tumor Biology in Patients With Resectable Glioblastoma", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Glioblastoma", "Recurrent Glioblastoma", "Resectable Glioblastoma" ], "interventions": [ { "name": "Biospecimen Collection", "type": "PROCEDURE" }, { "name": "Magnetic Resonance Imaging", "type": "PROCEDURE" }, { "name": "Medical Chart Review", "type": "OTHER" } ], "intervention_types": [ "PROCEDURE", "OTHER" ], "sponsor": "Jonsson Comprehensive Cancer Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 50, "start_date": "2022-04-14", "completion_date": "2028-04-18", "has_results": false, "last_update_posted_date": "2025-11-10", "last_synced_at": "2026-09-26T02:55:01.380Z", "location_count": 1, "location_summary": "Los Angeles, California", "locations": [ { "city": "Los Angeles", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT06090903" }, { "nct_id": "NCT02740699", "title": "CT COMPARE: CT Coronary Angiography to Measure Plaque Reduction", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Cardiovascular Disease" ], "interventions": [ { "name": "Rosuvastatin", "type": "DRUG" }, { "name": "Atorvastatin", "type": "DRUG" }, { "name": "Cardiac Computed Tomography (CT)", "type": "RADIATION" }, { "name": "Cardiac Magnetic Resonance Image (MRI)", "type": "RADIATION" } ], "intervention_types": [ "DRUG", "RADIATION" ], "sponsor": "National Heart, Lung, and Blood Institute (NHLBI)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "40 Years to 75 Years" }, "enrollment_count": 79, "start_date": "2016-04-11", "completion_date": "2022-03-11", "has_results": true, "last_update_posted_date": "2024-10-09", "last_synced_at": "2026-09-26T02:55:01.380Z", "location_count": 1, "location_summary": "Bethesda, Maryland", "locations": [ { "city": "Bethesda", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT02740699" }, { "nct_id": "NCT06391034", "title": "Magnetic Resonance (MR) Imaging With Hyperpolarized 13C-Pyruvate +/- 13C,15N-Urea in Patients With Prostate Cancer", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Prostate Cancer" ], "interventions": [ { "name": "hyperpolarized pyruvate +/-urea (13C/15N)", "type": "DRUG" }, { "name": "Non-investigational External beam radiotherapy (EBRT)", "type": "RADIATION" }, { "name": "Radiotherapy (RT)", "type": "PROCEDURE" }, { "name": "Multi-parametric magnetic resonance imaging (mpMRI)", "type": "PROCEDURE" }, { "name": "Non-interventional hormone therapy", "type": "BIOLOGICAL" }, { "name": "Prostate Biopsy", "type": "PROCEDURE" } ], "intervention_types": [ "DRUG", "RADIATION", "PROCEDURE", "BIOLOGICAL" ], "sponsor": "Robert Bok, MD, PhD", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "MALE", "summary": "18 Years and older · Male only" }, "enrollment_count": 161, "start_date": "2024-09-24", "completion_date": "2032-10-31", "has_results": false, "last_update_posted_date": "2026-01-07", "last_synced_at": "2026-09-26T02:55:01.380Z", "location_count": 1, "location_summary": "San Francisco, California", "locations": [ { "city": "San Francisco", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT06391034" }, { "nct_id": "NCT01592565", "title": "Exercise Cardiac Magnetic Resonance Imaging Accuracy for Cardiovascular Stress Testing", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Coronary Artery Disease" ], "interventions": [ { "name": "Diagnostic Cardiac Imaging", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Ohio State University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 227, "start_date": "2010-08", "completion_date": null, "has_results": false, "last_update_posted_date": "2017-01-27", "last_synced_at": "2026-09-26T02:55:01.380Z", "location_count": 3, "location_summary": "Cinncinatti, Ohio • Columbus, Ohio • Pittsburgh, Pennsylvania", "locations": [ { "city": "Cinncinatti", "state": "Ohio" }, { "city": "Columbus", "state": "Ohio" }, { "city": "Pittsburgh", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT01592565" }, { "nct_id": "NCT01255553", "title": "Partial Breast Irradiation in a Low-risk Population Screened With MRI", "overall_status": "WITHDRAWN", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Breast Cancer" ], "interventions": [ { "name": "Partial Breast Irradiation", "type": "RADIATION" } ], "intervention_types": [ "RADIATION" ], "sponsor": "University of Chicago", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": null, "sex": "FEMALE", "summary": "40 Years and older · Female only" }, "enrollment_count": 0, "start_date": "2009-06", "completion_date": "2012-05", "has_results": false, "last_update_posted_date": "2014-03-04", "last_synced_at": "2026-09-26T02:55:01.380Z", "location_count": 1, "location_summary": "Chicago, Illinois", "locations": [ { "city": "Chicago", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT01255553" }, { "nct_id": "NCT05101239", "title": "Acute and Mild TBI Injury in Military and Civilian Population Using Advanced MR Imaging", "overall_status": "UNKNOWN", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Mild Traumatic Brain Injury" ], "interventions": [ { "name": "MRI imaging exam", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "The Geneva Foundation", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "ALL", "summary": "18 Years to 55 Years" }, "enrollment_count": 160, "start_date": "2019-11-08", "completion_date": "2026-06-30", "has_results": false, "last_update_posted_date": "2023-09-26", "last_synced_at": "2026-09-26T02:55:01.380Z", "location_count": 2, "location_summary": "Bethesda, Maryland • Fort Belvoir, Virginia", "locations": [ { "city": "Bethesda", "state": "Maryland" }, { "city": "Fort Belvoir", "state": "Virginia" } ], "official_url": "https://clinicaltrials.gov/study/NCT05101239" }, { "nct_id": "NCT05477823", "title": "Imaging and Genomic Biomarkers to Predict Response in Prostate Cancer", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "EARLY_PHASE1" ], "conditions": [ "Prostate Cancer" ], "interventions": [ { "name": "External beam radiation therapy", "type": "RADIATION" }, { "name": "Prostate brachytherapy boost", "type": "RADIATION" }, { "name": "Androgen deprivation therapy", "type": "DRUG" }, { "name": "Positron emission tomography (PET)/magnetic resonance imaging (MRI)", "type": "DIAGNOSTIC_TEST" } ], "intervention_types": [ "RADIATION", "DRUG", "DIAGNOSTIC_TEST" ], "sponsor": "University of Wisconsin, Madison", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 30, "start_date": "2023-03-08", "completion_date": "2027-08", "has_results": false, "last_update_posted_date": "2026-06-02", "last_synced_at": "2026-09-26T02:55:01.380Z", "location_count": 1, "location_summary": "Madison, Wisconsin", "locations": [ { "city": "Madison", "state": "Wisconsin" } ], "official_url": "https://clinicaltrials.gov/study/NCT05477823" }, { "nct_id": "NCT05805839", "title": "A Study of Imaging in Demyelinating Diseases", "overall_status": "ENROLLING_BY_INVITATION", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Multiple Sclerosis", "Inflammatory Demyelinating Disease" ], "interventions": [ { "name": "C-11 ER176 Radiotracer", "type": "DRUG" }, { "name": "C11 Pittsburgh Compound B", "type": "DRUG" }, { "name": "PET/CT scan", "type": "DIAGNOSTIC_TEST" }, { "name": "MRI", "type": "DIAGNOSTIC_TEST" } ], "intervention_types": [ "DRUG", "DIAGNOSTIC_TEST" ], "sponsor": "Mayo Clinic", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 200, "start_date": "2023-07-10", "completion_date": "2028-05", "has_results": false, "last_update_posted_date": "2026-09-17", "last_synced_at": "2026-09-26T02:55:01.380Z", "location_count": 1, "location_summary": "Rochester, Minnesota", "locations": [ { "city": "Rochester", "state": "Minnesota" } ], "official_url": "https://clinicaltrials.gov/study/NCT05805839" }, { "nct_id": "NCT05336695", "title": "Assess Fibrin in Brains With AD/ADRD", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Alzheimer Disease", "Dementia of Alzheimer Type" ], "interventions": [ { "name": "PET/MR Imaging", "type": "DIAGNOSTIC_TEST" }, { "name": "64Cu-FBP8", "type": "DRUG" } ], "intervention_types": [ "DIAGNOSTIC_TEST", "DRUG" ], "sponsor": "Massachusetts General Hospital", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "55 Years", "maximum_age": "90 Years", "sex": "ALL", "summary": "55 Years to 90 Years" }, "enrollment_count": 30, "start_date": "2022-03-29", "completion_date": "2026-09-28", "has_results": false, "last_update_posted_date": "2025-10-30", "last_synced_at": "2026-09-26T02:55:01.380Z", "location_count": 1, "location_summary": "Boston, Massachusetts", "locations": [ { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT05336695" } ] }